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Abstracts  
Background: The prevalence of hyperuricemia has 
increased overtime globally. Moreover, it has been linked 
with several metabolic syndromes. A study in Depok City 
and Denpasar showed prevalence of hyperuricemia were 
up to 18.6% and 18.2%, respectively. Urban lifestyle has 
been proposed to contribute for hyperuricemia; however, 
there is no published study conducted in rural population 
yet. Therefore, we performed this study to evaluate the 
prevalence and metabolic syndromes profile of 
hyperuricemic patients in rural area.  
Methods: A cross sectional study was conducted at 
regional government hospital in North Kayong Regency, 
West Kalimantan. We retrieved all complete internal 
medicine outpatient data between October and 
December 2018. All non-pregnant, adult patients newly 
diagnosed with hyperuricemia or currently taking uric 
acid lowering drug were included in this study. 
Result: A total of 44 out of 121 subjects (36.36%) had 
hyperuricemia; 25 subjects (56.81%) were male and had 
median age of 53 years old. Mean level of serum uric 
acid was 8.30±1.77mg/dl. The metabolic syndrome 
profiles (diabetes mellitus, obesity, hypertension, 
hypercholesterolemia and hypertriglyceridemia) 
vary among subjects; ranging from 20.45% 
(hypertriglyceridemia) to 86.36% 
(hypertension). Conclusion: Hyperuricemia 
and its metabolic disorders are an emerging 
burden of disease in rural area in Indonesia.  
Keywords: Hyperuricemia, metabolic 
syndrome, prevalence  
 
 
Introduction 
The prevalence hyperuricemia is increasing globally. 
Previously, hyperuricemia was known to be more 
prevalent in developed country than developing 
country. Prevalence of hyperuricemia in US was 
21.4% while in Bangladesh, the prevalence was 9.3% 
(men vs women; 8.4% vs 10.2%). However, this 
presented the fact that hyperuricemia was also 
common not only in advanced countries, but also in 
developing countries.1, 2 However, there was no actual 
prevalence of hyperuricemia in Indonesia. Several 
studies conducted in urban area of Indonesia. In 
Depok City, West Java, prevalence of hyperuricemia 
was 18.6%, while in Denpasar, 
 
Bali the prevalence was 18.2%.3, 4  
Balance between uric acid production and renal 
excretion determines the level of serum uric acid. 
Multiple factors such as race or inheritance, gender, 
age, obesity, hormones, dietary changes including 
greater of purine-rich processed foods, alcohol, 
fructose, lifestyles, and increasing use of diuretics 
affect serum uric acid level and eventually 
prevalence of hyperuricemia.5, 6  
Hyperuricemia has been known for its role in 
gouty arthritis or kidney stones. Increasing 
comorbidities associated with hyperuricemia 
including hypertension, diabetes mellitus, 
hyperlipidemia, and morbid obesity favor 
hyperuricemia to be involved in pathophysiology of 
metabolic syndromes.6 Underlying mechanisms 
involved in both fat storage and genetic factors. Recent 
studies also suggest the role of nucleic acid 
metabolism where stimulation of adenosine 
monophosphate (AMP) deaminase which promotes fat 
storage and insulin resistance. Therefore, uric acid 
appears as a key factor to promote fat storage. Another 
mechanism presented as high level of serum uric acid 
may trigger oxidative stress to vascular and leads to 
endothelial dysfunction. These are associated with the 
risk of atherosclerosis. Eventually, hyperuricemia is 
an important remediable risk factor for metabolic and 
cardiovascular diseases. 7, 8 
 
Up until now, there was no published study 
conducted in rural area in Indonesia. The objective 
of the study is to evaluate the prevalence and 
metabolic syndromes profile of hyperuricemic 
patients in rural area. 
 
Methods 
This is a primary cross-sectional study on 
hyperuricemia subjects in rural population that 
conducted at regional government hospital in North 
Kayong Regency, West Kalimantan. The object of the 
study was all complete internal medicine outpatient 
data between October and December 2018. All non-
pregnant, adult patients newly diagnosed with 
hyperuricemia or currently taking uric acid lowering 
drug were included in this study. Subjects with CKD 
stage 3-5 were excluded from the study. The aim and 
method of the study were.
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approved by hospital’s ethic review board.  
Subject’s characteristic was collected from the medical 
records. Hyperuricemia was define as serum uric acid ≥ 7 
mg/dL for male subjects and ≥ 6 mg/dL for female subjects.9 
For the metabolic profiles; subjects with body mass index  
≥ 25 kg/m2 were categorized as obese. 10 Using the ESC/ ESH 
criteria, hypertension was determined as systolic blood pressure 
(SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 
mmHg.11 The presence of diabetes mellitus (DM) in subjects was 
determined by fasting blood glucose : ≥  
126 mg/dL and /or 2 h pp blood glucose : ≥ 200 mg/dL.12 
Hypercholestrolemia was defined as subject’s total cholesterol  
≥ 200 mg/dL, while hypertriglyceridemia was define as 
serum triglycerides ≥ 150 mg/dL.13 Descriptive statistics are 
presented as mean ± standard deviation (SD) for continuous 
variables and percentages for categorical variables. Data were 
presented using frequency tabulation in tables. 
 
Results 
A total of 44 out of 121 (36.36%) internal medicine outpatients 
had hyperuricemia. Hyperuricemia was found slightly higher in 
male rather than female subjects (56.81% and 43.19%, 
respectively). Median age of the subjects was 53 years old (male 
vs female; 55 years old vs 60 years old). Mean uric acid level was 
8.30±1.77mg/dL; higher in male than female subjects 
(8.75±1.76mg/dL vs 7.72 ± 1.69 mg/dL). 
 
Table 1. Metabolic Profiles of Hyperuricemia Subjects  
Metabolic Profiles Frequency (n) Percentage (%) 
Hypertension 38 86.36 
Diabetes Mellitus 11 25 
Obesity 11 25 
Hypercholestrolemia 17 38.60 
Hypertriglyceridemia 9 20.45 
 
Table 2. Comorbidities of Hyperuricemia Subjects  
Comorbidities 
Frequency Percentage 
(n) (%)  
1 comorbities 18 41 
2 comorbidites 11 25 
Hypertension and Obese 3 27 
Hypertension and DM 3 27 
Hypertension and Hypercholestrolemia 4 37 
Hypertension and Hypertriglyceridemia 1 9 
3 comorbidites 13 25 
Hypertension, DM, Hypercholestrolemia 3 23.08 
Hypertension, DM, Hypertriglyceridemia 3 23.08 
Hypertension, Obese, Hypercholestrolemia 3 23.08 
Hypertension, Obese Hypertriglyceridemia 1 0.77 
Hypertension, Hypercholestrolemia, Hypertriglyceridemia 3 23.08 
4 or more comorbidities 2 4 
DM= Diabetes Mellitus   
 
Hypertension was found to be most common comorbid in 
hyperuricemia subjects. On contrary, hypertriglyceridemia was 
the least common comorbid among the subjects (Table 1). All 
subjects had at least one metabolic comorbid. About 30% 
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subjects had three metabolic comorbidities. Interestingly, 4% 
of the subjects had four or all metabolic comorbidities (Table 
2). 
 
Discussion 
Prevalence of hyperuricemia in the study was higher in 
comparison to studies from other countries such as US 
(21.4%), China (8.4%), Northeast China (10.85%), Thailand  
(10.46%).2, 14-16 In comparison to other big cities (Depok and 
Denpasar; 18.6% and 18.2%. respectively) in Indonesia, 
prevalence of hyperuricemia in this rural area was also higher.3,  
4 Genetic might influence hyperuricemia prevalence in this 
study. A study in Northern Sulawesi, Indonesia presented that 
genetic is considered as one of prominent risk factors (OR 
14.42 (8.01–26.23) p < 0.0001). 17 Another heritability 
analytical study for hyperuricemia and gout presented that 
hyperuricemia had stronger genetic trait that gout. The 
concordance of hyperuricemia was 53% in monozygotic twin 
pairs and 24% in dizygotic twin pairs (p< 0.001).18, 19 
 
Previous study presented that estrogen has uricosuric 
activity due to post-secretory tubular reabsorption of uric acid. 
Furthermore hormonal replacement therapy was found to be 
effective in reducing uric acid levels. Fifty years or older 
women had the their serum uric acid levels increased , at which 
age most women were in menopause and estrogen levels 
decreased greatly.20 Hence, hyperuricemia was more common 
in men. Another study by Guan et al demonstrated the 
prevalence of hyperuricemia increased with age, with the 
highest prevalence among subjects age 65 years or older.21 
This corresponds well with this study that median age of 
female subjects with hyperuricemia was 60 years old. 
 
Another risk factor that might influence the prevalence of 
hyperuricemia in the study was diet. High purine diet showed a 
significant relationship with hyperuricemia (OR 26.72; 95% CI 
11.69-61.04; p < 0.001).4 Previous study also showed 
hyperuricemia subjects had poor diet quality including low 
vegetable and dairy product intake (p<0.0001).22 While most 
common diet in this study population were shellfish, offals and 
low vegetable intake. However, no data regarding each subject’s 
diet quality and quantity presented in this study. 
 
Prolonged sitting and lack of physical activity were an 
independent risk factors for increase serum uric acid level 
(p<0.001). Elevated serum uric acid level were caused by 
reduce insulin sensitivity and increase urine volume.5 Most 
common occupation of our study population including farmer, 
fishermen, housewife, and employee. Although, there were no 
data of time quantity of subject’s physical activity. 
 
This first pilot study regarding hyperuricemia in rural area in 
Indonesia still has some limitation as we could not present the 
correlation between influencing factors and hyperuricemia. 
 
Further studies regarding their correlation were needed. 
 
Conclussion 
Hyperuricemia and its metabolic profiles are an emerging 
burden of disease in rural area in Indonesia. 
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